Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +121.8% | -51.9% | 1 / 3 | -8.1% | +2.48 pp | -2.74 pp | +3.0% | 0.03 | 41.51 | 26,3 | −8,1% | 2,3 | −29,8% | 41.51 | 12.72 | +226,3% |
| Pts | 12 | 0 | 4 | 0 | 8 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 10.000 (close price on 2026-10-12)EPS (TTM): 240,9
Financial charts
1.Revenue & growth
VND bn26,3Q2/26
1.Revenue & growth
VND bn26,3Q2/26
2.Profit & growth
VND bn2,33Q2/26
3.Profit mix (Penman)
VND bn11,7Q2/26
4.Margins & cost structure
%43.6%Q2/26
5.Returns & cash cycle
% · days3.4%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn182Q2/26
8.Funding & debt health
VND bn · times182Q2/26
9.Revenue backlog
VND bn0,61Q2/26
10.Valuation
times · %22,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %228Q2/26
Adjusted EPS growth, latest quarter
127%
Average adjusted EPS growth, 3 quarters
-24.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26